Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Non-Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Non-Current Liabilities ₹17 Cr₹7.87 Cr₹3.19 Cr₹3.28 Cr₹1.79 Cr

What is the latest Total Non-Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Non-Current Liabilities ratio of NATH BIOGENES (INDIA) is ₹17 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹17 Cr
Mar2024₹7.87 Cr
Mar2023₹3.19 Cr
Mar2022₹3.28 Cr
Mar2013₹1.79 Cr

How is Total Non-Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹17 Cr
110.04
Mar2024 ₹7.87 Cr
146.55
Mar2023 ₹3.19 Cr
-2.60
Mar2022 ₹3.28 Cr
82.96
Mar2013 ₹1.79 Cr -

Compare Total Non-Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹317.0 Cr -1% -4.8% -12.8% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,770.3 Cr -5.4% -4.2% -31% Stock Analytics
KAVERI SEED COMPANY ₹5,503.0 Cr 7.1% 1.1% 15.6% Stock Analytics
VENKYS (INDIA) ₹1,912.2 Cr -0.2% -7.4% -23.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,229.5 Cr -4.1% -3.1% -27.1% Stock Analytics
INDO US BIOTECH ₹258.5 Cr -0.8% -0.3% -48.8% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-1%

-4.8%

-12.8%

SENSEX

1.6%

2.7%

6.3%


You may also like the below Video Courses